These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 10496309)

  • 1. Fully human anti-interleukin-8 monoclonal antibodies: potential therapeutics for the treatment of inflammatory disease states.
    Yang XD; Corvalan JR; Wang P; Roy CM; Davis CG
    J Leukoc Biol; 1999 Sep; 66(3):401-10. PubMed ID: 10496309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Production of antigen-specific human antibodies from mice engineered with human heavy and light chain YACs.
    Jakobovits A; Green LL; Hardy MC; Maynard-Currie CE; Tsuda H; Louie DM; Mendez MJ; Abderrahim H; Noguchi M; Smith DH; Zeng Y; David NE; Sasai H; Garza D; Brenner DG; Hales JF; McGuinness RP; Capon DJ; Klapholz S
    Ann N Y Acad Sci; 1995 Sep; 764():525-35. PubMed ID: 7486581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional transplant of megabase human immunoglobulin loci recapitulates human antibody response in mice.
    Mendez MJ; Green LL; Corvalan JR; Jia XC; Maynard-Currie CE; Yang XD; Gallo ML; Louie DM; Lee DV; Erickson KL; Luna J; Roy CM; Abderrahim H; Kirschenbaum F; Noguchi M; Smith DH; Fukushima A; Hales JF; Klapholz S; Finer MH; Davis CG; Zsebo KM; Jakobovits A
    Nat Genet; 1997 Feb; 15(2):146-56. PubMed ID: 9020839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Properties and pharmacokinetics of two humanized antibodies specific for L-selectin.
    Co MS; Landolfi NF; Nagy JO; Tan JH; Vexler V; Vasquez M; Roark L; Yuan S; Hinton PR; Melrose J; Klingbeil C; Queen C; Berg EL
    Immunotechnology; 1999 Mar; 4(3-4):253-66. PubMed ID: 10231094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preclinical efficacy and safety of pascolizumab (SB 240683): a humanized anti-interleukin-4 antibody with therapeutic potential in asthma.
    Hart TK; Blackburn MN; Brigham-Burke M; Dede K; Al-Mahdi N; Zia-Amirhosseini P; Cook RM
    Clin Exp Immunol; 2002 Oct; 130(1):93-100. PubMed ID: 12296858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An anti-interleukin 8 monoclonal antibody that interferes with the binding of interleukin 8 to cellular receptors and the activation of human blood neutrophils.
    Kurdowska A; Miller EJ; Cohen AB
    Hybridoma; 1995 Jun; 14(3):225-33. PubMed ID: 7590784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of recombinant rabbit IL-8 in Escherichia coli and establishment of the essential involvement of IL-8 in recruiting neutrophils into lipopolysaccharide-induced inflammatory site of rabbit skin.
    Harada A; Sekido N; Kuno K; Akiyama M; Kasahara T; Nakanishi I; Mukaida N; Matsushima K
    Int Immunol; 1993 Jun; 5(6):681-90. PubMed ID: 8347559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned?
    Feldmann M; Maini RN
    Annu Rev Immunol; 2001; 19():163-96. PubMed ID: 11244034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of murine anti-human Fab antibodies for use in an immunoassay for generic quantification of human Fab fragments in non-human serum samples including cynomolgus monkey samples.
    Stubenrauch K; Wessels U; Essig U; Kowalewsky F; Vogel R; Heinrich J
    J Pharm Biomed Anal; 2013 Jan; 72():208-15. PubMed ID: 23017233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutralizing murine monoclonal antibodies to human IL-5 isolated from hybridomas and a filamentous phage Fab display library.
    Ames RS; Tornetta MA; McMillan LJ; Kaiser KF; Holmes SD; Appelbaum E; Cusimano DM; Theisen TW; Gross MS; Jones CS
    J Immunol; 1995 Jun; 154(12):6355-64. PubMed ID: 7759873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibodies against the N-terminus of IL-8 receptor A inhibit neutrophil chemotaxis.
    Quan JM; Martin TR; Rosenberg GB; Foster DC; Whitmore T; Goodman RB
    Biochem Biophys Res Commun; 1996 Feb; 219(2):405-11. PubMed ID: 8605000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antigen-Specific Human Monoclonal Antibodies from Transgenic Mice.
    Mompó SM; González-Fernández Á
    Methods Mol Biol; 2019; 1904():253-291. PubMed ID: 30539474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The preclinical pharmacology of the high affinity anti-IL-6R Nanobody® ALX-0061 supports its clinical development in rheumatoid arthritis.
    Van Roy M; Ververken C; Beirnaert E; Hoefman S; Kolkman J; Vierboom M; Breedveld E; 't Hart B; Poelmans S; Bontinck L; Hemeryck A; Jacobs S; Baumeister J; Ulrichts H
    Arthritis Res Ther; 2015 May; 17(1):135. PubMed ID: 25994180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro and in vivo characterisation of anti-murine IL-13 antibodies recognising distinct functional epitopes.
    Berry LM; Adams R; Airey M; Bracher MG; Bourne T; Carrington B; Cross AS; Davies GC; Finney HM; Foulkes R; Gozzard N; Griffin RA; Hailu H; Lamour SD; Lawson AD; Lightwood DJ; McKnight AJ; O'Dowd VL; Oxbrow AK; Popplewell AG; Shaw S; Stephens PE; Sweeney B; Tomlinson KL; Uhe C; Palframan RT
    Int Immunopharmacol; 2009 Feb; 9(2):201-6. PubMed ID: 19041426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Double trans-chromosomic mice: maintenance of two individual human chromosome fragments containing Ig heavy and kappa loci and expression of fully human antibodies.
    Tomizuka K; Shinohara T; Yoshida H; Uejima H; Ohguma A; Tanaka S; Sato K; Oshimura M; Ishida I
    Proc Natl Acad Sci U S A; 2000 Jan; 97(2):722-7. PubMed ID: 10639146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation and characterization of a human monoclonal autoantibody that acts as a high affinity interleukin-1 alpha specific inhibitor.
    Garrone P; Djossou O; Fossiez F; Reyes J; Ait-Yahia S; Maat C; Ho S; Hauser T; Dayer JM; Greffe J; Miossec P; Lebecque S; Rousset F; Banchereau J
    Mol Immunol; 1996; 33(7-8):649-58. PubMed ID: 8760277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody engineering via genetic engineering of the mouse: XenoMouse strains are a vehicle for the facile generation of therapeutic human monoclonal antibodies.
    Green LL
    J Immunol Methods; 1999 Dec; 231(1-2):11-23. PubMed ID: 10648924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of pharmacodynamic activity, pharmacokinetics, and anti-product antibody responses to anti-IL-21R antibody therapeutics following IV administration to cynomolgus monkeys.
    Vugmeyster Y; Allen S; Szklut P; Bree A; Ryan M; Ma M; Spaulding V; Young D; Guay H; Bloom L; Leach MW; O'Toole M; Adkins K
    J Transl Med; 2010 Apr; 8():41. PubMed ID: 20420683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of interleukin 1 (IL-1) binding and bioactivity in vitro and modulation of acute inflammation in vivo by IL-1 receptor antagonist and anti-IL-1 receptor monoclonal antibody.
    McIntyre KW; Stepan GJ; Kolinsky KD; Benjamin WR; Plocinski JM; Kaffka KL; Campen CA; Chizzonite RA; Kilian PL
    J Exp Med; 1991 Apr; 173(4):931-9. PubMed ID: 1826128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antigen-specific human monoclonal antibodies from mice engineered with human Ig heavy and light chain YACs.
    Green LL; Hardy MC; Maynard-Currie CE; Tsuda H; Louie DM; Mendez MJ; Abderrahim H; Noguchi M; Smith DH; Zeng Y; David NE; Sasai H; Garza D; Brenner DG; Hales JF; McGuinness RP; Capon DJ; Klapholz S; Jakobovits A
    Nat Genet; 1994 May; 7(1):13-21. PubMed ID: 8075633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.